Filing Flows › Pelthos Therapeutics (PTHS) › How it makes money
How Pelthos Therapeutics (PTHS) makes money
Pelthos Therapeutics (PTHS) made $15.6M of revenue in the second quarter 2026 (Q2 2026). Net product revenues brought in $15.4M (99%); License and collaboration revenues brought in $183K (1%).
Drawing the Sankey…
Revenue by segment, Q2 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Net product revenues | $15.4M | 98.8% | — | — |
| License and collaboration revenues | $183K | 1.2% | — | — |
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $15.6M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $15.6M | — |
| Q1 2026 | $10.9M | — |
| Q4 2025 | $9.4M | — |
| Q3 2025 | $7.4M | — |
From Pelthos Therapeutics' 10-Q filed Aug 13, 2026 (on EDGAR).
Questions
How does Pelthos Therapeutics make money?
Pelthos Therapeutics (PTHS) made $15.6M of revenue in the second quarter 2026 (Q2 2026). Net product revenues brought in $15.4M (99%); License and collaboration revenues brought in $183K (1%).
What is Pelthos Therapeutics' biggest business?
Net product revenues: $15.4M in the second quarter 2026, 99% of revenue.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.